Exploring mHealth potential to improve kidney function: secondary analysis of a randomized trial of diabetes self-care in diverse adults
- PMID: 35948873
- PMCID: PMC9364602
- DOI: 10.1186/s12882-022-02885-6
Exploring mHealth potential to improve kidney function: secondary analysis of a randomized trial of diabetes self-care in diverse adults
Abstract
Background: Many individuals living with chronic kidney disease (CKD) have comorbid Type 2 diabetes (T2D). We sought to explore if efficacious interventions that improve glycemic control may also have potential to reduce CKD progression.
Methods: REACH is a text message-delivered self-management support intervention, which focused on medication adherence, diet, and exercise that significantly improved glycemic control in N = 506 patients with T2D. Using data from the trial, we characterized kidney health in the full sample and explored the intervention's effect on change in estimated glomerular filtration rate (eGFR) at 12 months in a subsample of N=271 patients with eGFR data.
Results: In a diverse sample with respect to race/ethnicity and socioeconomic status, 37.2% had presence of mild or heavy proteinuria and/or an eGFR < 60 mL/min/1.73 m2. There was a trending interaction effect between intervention and presence of proteinuria at baseline (b = 6.016, p = .099) such that patients with proteinuria at baseline who received REACH had less worsening of eGFR.
Conclusions: Future research should examine whether diabetes directed self-management support reduces CKD progression in ethnically diverse individuals with albuminuria. In highly comorbid populations, such as T2D and CKD, text-based support can be further tailored according to individuals' multimorbid disease self-management needs and is readily scalable for individuals with limited resources.
Trial registration: This study was registered with ClinicalTrials.gov ( NCT02409329 ).
Keywords: Chronic kidney disease (CKD); Type 2 diabetes (T2D); mHealth.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.BMC Nephrol. 2020 May 7;21(1):167. doi: 10.1186/s12882-020-01792-y. BMC Nephrol. 2020. PMID: 32380961 Free PMC article.
-
Mobile Phone Support for Diabetes Self-Care Among Diverse Adults: Protocol for a Three-Arm Randomized Controlled Trial.JMIR Res Protoc. 2018 Apr 10;7(4):e92. doi: 10.2196/resprot.9443. JMIR Res Protoc. 2018. PMID: 29636319 Free PMC article.
-
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.BMC Nephrol. 2016 Nov 8;17(1):168. doi: 10.1186/s12882-016-0383-7. BMC Nephrol. 2016. PMID: 27825313 Free PMC article. Clinical Trial.
-
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.BMJ Open Diabetes Res Care. 2022 Jul;10(4):e002806. doi: 10.1136/bmjdrc-2022-002806. BMJ Open Diabetes Res Care. 2022. PMID: 35790319 Free PMC article. Review.
-
Therapeutic Exercise on Metabolic and Renal Outcomes in Patients with Chronic Kidney Disease: A Narrative Review.Nephron. 2024;148(2):85-94. doi: 10.1159/000531921. Epub 2023 Aug 23. Nephron. 2024. PMID: 37611542 Review.
Cited by
-
Development of Chronic Kidney Disease Screening Integrative Care Model Led by Community Pharmacists.Pharmacy (Basel). 2025 Feb 14;13(1):27. doi: 10.3390/pharmacy13010027. Pharmacy (Basel). 2025. PMID: 39998025 Free PMC article.
-
Education programmes for people with chronic kidney disease and diabetes.Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD007374. doi: 10.1002/14651858.CD007374.pub3. Cochrane Database Syst Rev. 2024. PMID: 39171639 Free PMC article.
References
-
- Federation ID . Idf diabetes atlas. 2013. Brussels: International Diabetes Federation, 6th edn[Google Scholar]; 2015. - PubMed
-
- Holman N, Forouhi N, Goyder E, Wild S. The Association of Public Health Observatories (APHO) diabetes prevalence model: estimates of total diabetes prevalence for England, 2010–2030. Diabet Med. 2011;28(5):575–582. - PubMed
-
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. - PubMed
-
- Kaiser AB, Zhang N, Der Pluijm WV. Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028) Diabetes. 2018;67(Supplement 1):202–2LB.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous